z-logo
open-access-imgOpen Access
Amylin and Hypertension: Association of an Amylin −G132A Gene Mutation and Hypertension in Humans and Amylin-Induced Endothelium Dysfunction in Rats
Author(s) -
Anovials,
Leocadio Rodrı́guez-Mañas,
Ana Chico,
Mariam El Assar,
Sı́lvia Casas,
Ramón Gomis
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2006-1980
Subject(s) - amylin , medicine , endocrinology , diabetes mellitus , population , endothelium , endothelial dysfunction , environmental health , islet
Amylin has been linked to the development of hypertension in several pathological states related to hypertension and insulin resistance, although there is scant data regarding its potential mechanisms of action. The -132 G/A mutation located within an activator domain of the amylin gene's promoter was first identified in a small cohort of Spanish patients with type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom